1. Home
  2. RLMD vs MGRX Comparison

RLMD vs MGRX Comparison

Compare RLMD & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • MGRX
  • Stock Information
  • Founded
  • RLMD 2004
  • MGRX 2021
  • Country
  • RLMD United States
  • MGRX United States
  • Employees
  • RLMD N/A
  • MGRX N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • MGRX Computer Software: Prepackaged Software
  • Sector
  • RLMD Health Care
  • MGRX Technology
  • Exchange
  • RLMD Nasdaq
  • MGRX Nasdaq
  • Market Cap
  • RLMD 20.3M
  • MGRX 18.6M
  • IPO Year
  • RLMD N/A
  • MGRX 2023
  • Fundamental
  • Price
  • RLMD $0.59
  • MGRX $1.71
  • Analyst Decision
  • RLMD Buy
  • MGRX
  • Analyst Count
  • RLMD 3
  • MGRX 0
  • Target Price
  • RLMD $5.00
  • MGRX N/A
  • AVG Volume (30 Days)
  • RLMD 206.5K
  • MGRX 144.3K
  • Earning Date
  • RLMD 08-07-2025
  • MGRX 08-13-2025
  • Dividend Yield
  • RLMD N/A
  • MGRX N/A
  • EPS Growth
  • RLMD N/A
  • MGRX N/A
  • EPS
  • RLMD N/A
  • MGRX N/A
  • Revenue
  • RLMD N/A
  • MGRX $511,084.00
  • Revenue This Year
  • RLMD N/A
  • MGRX N/A
  • Revenue Next Year
  • RLMD N/A
  • MGRX N/A
  • P/E Ratio
  • RLMD N/A
  • MGRX N/A
  • Revenue Growth
  • RLMD N/A
  • MGRX N/A
  • 52 Week Low
  • RLMD $0.24
  • MGRX $1.32
  • 52 Week High
  • RLMD $3.98
  • MGRX $7.66
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 44.70
  • MGRX 51.65
  • Support Level
  • RLMD $0.60
  • MGRX $1.61
  • Resistance Level
  • RLMD $0.67
  • MGRX $1.77
  • Average True Range (ATR)
  • RLMD 0.06
  • MGRX 0.14
  • MACD
  • RLMD -0.00
  • MGRX 0.02
  • Stochastic Oscillator
  • RLMD 16.42
  • MGRX 43.68

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Share on Social Networks: